11/26/2012. Implementation of Florida s PDMP. Disclosure
|
|
- Jack Garrett
- 8 years ago
- Views:
Transcription
1 Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or grant money for this continuing education program, or any affiliation with any organization whose philosophy could potentially bias my presentation. 1
2 OBJECTIVES Provide overview of Florida s Prescription Drug Monitoring Program regulations Discuss data reporting requirements Demonstrate health care practitioner registration Demonstrate health care practitioner Query~ Patient Advisory Report Discuss outcomes BACKGROUND The purpose of the PDMP is to provide information collected in the database to health care practitioners to guide their clinical decisions in prescribing and dispensing these highly-abused prescription drugs. 2
3 DEFINITIONS Section (1), F.S.: A dispenser means a pharmacy, a dispensing pharmacist, or a dispensing health care practitioner. A health care practitioner means any practitioner who is subject to licensure or regulation by the department under chapters 458, 459, 461, 462, 464, 465, or 466, F.S. DEFINITIONS CONTINUED Section (1), F.S.: Administer means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a person or animal. REPORTING REQUIREMENTS Pharmacy and dispensing practitioners must report within 7 days of dispensing a controlled substance in schedules II, III and IV to an individual Mandatory reporting began September 1, 2011 E-FORCSE requested dispensers report retroactive data from December 1, 2010 >53 MILLION records in database. 3
4 REPORTED INFORMATION Patient Demographics Date of Birth Gender Prescriber Demographics DEA Number NPI Number State License Number Pharmacy DEA Number Rx Number Date written, date filled Refill Number Drug Name Strength Dosage Form Quantity Payment Type CS INFORMATION NOT REPORTED If administered directly to a patient during that particular treatment session; If administered to a patient receiving care in a hospital or emergency room, nursing home, ambulatory surgical center, hospice, intermediate care facility for developmentally disabled; If administered or dispensed in the health care system of the Department of Corrections; If administered or dispensed to a patient less than 16 years of age; If dispensed one-time 72-hour re-supply to a patient; If prescribed by a health care practitioner; or If prescribed or dispensed by a health care practitioner in a DOD/VA facility. PENALTY FOR NON-COMPLIANCE A health care practitioner who willfully and knowingly fails to report the dispensing of a controlled substance as required by section , F.S., commits a first degree misdemeanor. 4
5 AUTHORITY TO ACCESS THE DATABASE Section (7)(b), F.S.: A pharmacy, prescriber, or dispenser shall have access to information in the prescription drug monitoring program s database which relates to a patient of that pharmacy, prescriber, or dispenser for the purpose of reviewing the patient s controlled substance prescription history. PUBLIC RECORD EXEMPTION Section , F.S., any person who willfully and knowingly violates this section of law by sharing confidential protected health information commits a felony of the third degree. ACCESSING THE RxSENTRY SITE RxSentry site: 5
6 Requesting an account Creating query requests Viewing query request status Generating reports Viewing patient records 6
7 LOGGING ON TO FL RxSENTRY User Name: newacct Password: welcome 7
8 Patient Advisory Report Request QUERY SITE Click Query Site Type in User ID Type in Password Click OK License # PDMP Menu 8
9 PRACTITIONER DISCLAIMER PRACTITIONER QUERY SCREEN PRACTITIONER PATIENT SELECTION 9
10 VIEW QUERY STATUS Approved/Queued- the query has been approved and is processing Approved/Done- the query has been approved, processed, and is available for viewing PATIENT ADVISORY REPORT 10
11 VIEW PATIENT ADVISORY REPORTS Open open the report for viewing and printing (if desired) Save save the report to a specific location for viewing and printing (if desired) at a later time. Cancel 11
12 PERFORMANCE MEASURES Outcome: Reduction of the rate of inappropriate use of prescription drugs through education and safety efforts Measure: The number of licensed prescribers, dispensers, and individuals authorized to conduct investigations that were trained in the use of the state's PDMP system. Controlled Substance Prescriptions Reported by Dispensers Number of Pharmacies / Dispensers who have reported to the PDMP 6,391 Number of prescription records reported to the PDMP 55,041,371 NUMBER OF PDMP REGISTERED USERS Healthcare Practitioners 18,385 Law Enforcement Officers 546 TOTAL 18,931 12
13 NUMBER OF PATIENT ADVISORY REPORT REQUESTS= 2.5 MILLION PERFORMANCE MEASURES Measure: The number of coroner reports that indicate controlled substance prescription drug use as the primary or contributing cause of death. 1 13
14 PERFORMANCE MEASURES Outcome: Reduction of the quantity of pharmaceutical controlled substances obtained by individuals attempting to engage in fraud and deceit. Measure: The number of individuals obtaining controlled substance prescriptions from X or more prescribers and X or more pharmacies in a 90 day period. 2 14
15 DOH RULEMAKING Rule 64K-1, Florida Administrative Code Rule Promulgation 64K Indicators of Controlled Substance Abuse System Enhancements Update User Profile 15
16 SYSTEM ENHANCEMENTS Interstate Data Exchange States Number of Prescriptions Issued by Florida Prescribers 2009 Alabama 116,000 Louisiana 16,000 North Carolina 48,000 South Carolina 28,000 Arizona 14,000 Vermont 1,700 Total 223,700 Future System Enhancements Integration into Clinical Workflows 16
17 Future System Enhancements Integration into Electronic Health Record Primary Care Practice Future System Enhancements Real Time Data Reporting Presentation Summary Reviewed Florida s Prescription Drug Monitoring Program regulations Discussed data reporting requirements Demonstrated health care practitioner registration Demonstrated health care practitioner Query~ Patient Advisory Report Discussed performance measures and program outcomes 17
18 Conclusion Physicians and pharmacists have queried 53 million records more than 2.3 million times to improve clinical decision making, help reduce diversion and abuse of controlled substances and to assist in curbing the prescription drug abuse epidemic in Florida. PDMP must become a routine part of every clinical practice not because it s mandated, but because it makes good clinical sense. Future of PDMP includes building integration into existing workflow and technology, interoperability of data between states, strengthening partnerships, and identifying sustainable funding. Questions How often does a pharmacy need to upload a or report dispensing information to the PDMP? a. 10 days b. 15 days c. 7 days d. Real time Questions True or False I am required to view my patient s specific controlled substance history prior to dispensing a controlled substance. 18
19 Questions What is the penalty for a health care practitioner that does not report their Schedule II-IV controlled substance dispensing data? a. Felony b. Misdemeanor Questions What is the penalty for disclosure of confidential information in the E-FORCSE database? a. Felony b. Misdemeanor Need Technical Assistance? Contact Health Information Designs, Inc. for Technical Support & Assistance: Phone: flpdmp-info@hidinc.com Website: 8:00 am 5:00 pm EST 19
20 Need Program Assistance? Contact E-FORCSE Program Staff for non-technical assistance Phone: Website: Rebecca Poston, Program Manager Erika Marshall, Program Operations Administrator and Outreach Director QUESTIONS? References 1. Medical Examiner s Commission, Drugs Identified in Deceased Persons by Florida Medical Examiners, 2011 Report, Florida Department of Law Enforcement available at Report_Final.aspx 2. Florida Department of Health, Prescription Drug Monitoring Program Annual Report 2012 available at on December 1,
Implementation of Florida s PDMP. Rebecca Poston Program Manager
Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:
More informationFACT SHEET FOR HEALTH CARE PRACTITIONERS
Florida s Prescription Drug Monitoring Program http://www.e-forcse.com FACT SHEET FOR HEALTH CARE PRACTITIONERS The Florida Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Electronic- Florida
More informationPrescription Drug Abuse Florida s Health Crisis
Prescription Drug Abuse Florida s Health Crisis Overview Florida has been the epicenter for the diversion and abuse of prescription drugs. Prescription drugs killed almost 7 Floridians per day after an
More information2010-2011 Prescription Drug Monitoring Program Annual Report
2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription
More informationREFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 1381 Prescription Drug Monitoring Program SPONSOR(S): Davis TIED BILLS: IDEN./SIM. BILLS: REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF
More informationTraining Guide for Florida Practitioners and Pharmacists. Florida Department of Health Prescription Drug Monitoring Program
Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program January 2015 Contents Contents 1 Program Overview... 2 2 Document Overview...
More informationTraining Guide for Florida Practitioners and Pharmacists
Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program March 2014 Note This document is periodically updated. Please refer to the Florida
More informationFlorida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Florida Department of Health Department of Health Florida http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov
More informationAchieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
More informationAlaska Prescription Drug Monitoring Program
Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this
More informationTraining Guide for Government Agencies and Healthcare Administration
Training Guide for Government Agencies and Healthcare Administration Pharmacy Examining Board Wisconsin Department of Safety and Professional Services May 2013 Contents Contents 1 Document Overview...
More informationControlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy
Controlled Substances Prescription Monitoring Program Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Arizona s Forty-eighth Legislature passed H.B.
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is
More informationTraining Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program
Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program August 2014 v1.7 Contents Contents 1 Document Overview... 1 Purpose
More informationFrequently Asked Questions
This document provides answers to some common questions regarding the reporting of controlled substances to the New Hampshire (PDMP) database. A list of the questions answered in this document is provided
More informationPDMP User s Guide. Oregon Health Authority Prescription Drug Monitoring Program
Oregon Health Authority Prescription Drug Monitoring Program December 2015 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 RxSentry Update... 1 2 System Overview... 3 About the RxSentry
More informationFrequently Asked Questions
This document provides answers to some common questions regarding the reporting of controlled substances to the Hawaii (HI PDMP) database. A list of the questions answered in this document is provided
More informationOregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:
Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain
More informationCURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
More informationDispenser s Implementation Guide
Alabama Department of Public Health Prescription Drug Monitoring Program October 2014 This document is formatted for duplex printing. This page intentionally left blank. Copyright 2009-2014 Health Information
More informationColorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
More information2014 Legislative Session. Florida Pharmacy Laws(Statutes) Disclosure. Objectives. 465.014 (1) Pharmacy Technician. Pharmacy Law Update 4/22/2014
2014 Legislative Session Pharmacy Law Update George Malone, PharmD Chair, FSHP Legal & Regulatory Affairs Council HB 323/SB 278 HB 7077/SB 662 HB 859/SB 962 SB 7016 HQS1 Relating to Pharmacy Technicians
More informationQuery and Reports Tutorial. Minnesota Board of Pharmacy Prescription Monitoring Program
Minnesota Board of Pharmacy Prescription Monitoring Program August 2015 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 RxSentry Update... 1 2 Accessing RxSentry... 3 Request an Account...
More informationPractitioner s Training Guide. North Carolina Department of Health and Human Services Controlled Substance Reporting System
North Carolina Department of Health and Human Services Controlled Substance Reporting System August 2014 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 2 System Overview... 2 About
More informationNOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS
NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this
More informationPill Mills, Non-Therapeutic Drug Use, and Prescription Drug Monitoring What to Look for During Investigations
Pill Mills, Non-Therapeutic Drug Use, and Prescription Drug Monitoring What to Look for During Investigations ffrey J. Mesaros, PharmD, JD ice Chair Florida Board of Pharmacy ay 21, 2013 Learning Objectives
More informationTable of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4
Table of Contents User Request for Access... 3 User Login... 3 Upload a Data File... 4 Add Patient Records Direct Dispenser Users... 5 Pharmacy... 8 Search for Patient Records... 10 Search for Error Records...
More information2014 Legislative Session. Disclosure. Florida Pharmacy Laws(Statutes) Objectives. 465.014 (1) Pharmacy Technician. FL Pharmacy Law Update May 24, 2014
2014 Legislative Session FL Pharmacy Law Update May 24, 2014 Norman Tomaka, MS, BS Pharm, FAPhA Board of Directors, FSHP HB 323/SB 278 HB 7077/SB 662 HB 859/SB 962 SB 7016 HQS1 Relating to Pharmacy Technicians
More informationCHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No.
CHAPTER 2010-211 Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. 2722 An act relating to controlled substances; amending s. 456.037,
More informationBureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014
Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Jeanne Tuttle, R.Ph. National Pharmacist Program Managers Pharmacy Benefits Management Services
More informationDelaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -
More informationSouth Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives
South Dakota Prescription Drug Monitoring Program (SD PDMP) SD Academy of Physician Assistants Summer/Fall CME Conference September 6, 2012 Ron Huether, RPh, SD PDMP Kari Shanard Koenders, RPh, PDMP Director
More informationMassachusetts. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted
More informationNew Mexico. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - PMP Director 5500 San Antonio Drive NE Albuquerque NM 87109 Office: (505) 222-9837 Fax: (505) 222-9845 Email: @state.nm.us
More informationDC DEPARTMENT OF HEALTH Pharmaceutical Procurement and Distribution Pharmaceutical Warehouse. DC Health Care Safety Net ALLIANCE PROGRAM
DC DEPARTMENT OF HEALTH Pharmaceutical Warehouse DC Health Care Safety Net ALLIANCE PROGRAM OPERATIONAL PROTOCOLS Operational protocols for the DC Health Care Alliance program through the DOH Pharmaceutical
More information2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS
2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS Research current through September 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationPain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to
Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations
More informationWashington. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington
More informationLouisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists
Chapter 17. Institutional Pharmacy Louisiana Administrative Code Title 46 Professional and Occupational Standards Subchapter A. General Requirements Part LIII: Pharmacists 1701. Cross References A. For
More informationManual of Instructions
NEW YORK STATE DEPARTMENT OF HEALTH OFFICIAL NEW YORK STATE PRESCRIPTION PROGRAM ELECTRONIC DATA TRANSMISSION Manual of Instructions New York State Department of Health Bureau of Narcotic Enforcement 433
More informationGeorgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Higgins, Ronnie - Special Agent 40 Pryor St SW, Ste 2000 Atlanta GA 30303 Office: (404) 656-5100 Fax: (404) 651-8210 Email: rhiggins@gdna.ga.gov
More informationNew Jersey. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Mielo, James - Administrator 124 Halsey St Newark NJ 07102 Office: (973) 273-8010 Fax: Email: NJPMRS mieloj@dca.lps.state.nj.us ASAP
More informationMaryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Jackson, Kate - PDMP Manager 55 Wade Ave Catonsville MD 21228 Office: (410) 402-8609 Fax: (410) 402-8601 Email: Maryland Department
More informationSouth Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc.
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Frick, Christie J. - Director (Rph) 2600 Bull St Columbia SC 29201 Office: (803) 896-0688 Fax: (803) 896-0686 Email: SCRIPTS frickcj@dhec.sc.gov
More informationMontana. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Montana Board of Pharmacy Pharmacy Board www.mpdr.mt.gov dlibsdmpdr@mt.gov Peterson, Donna - Program Manager PO Box 200513 Helena MT
More informationState Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations
State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,
More informationPrescribers required to check PDMP before first prescription for Controled Substances for new patient.
State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,
More informationPharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC
Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy
More informationArizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Arizona State Board of Pharmacy Pharmacy Board Wright, Dean - Program Director P O Box 18520 Phoenix AZ 85005 Office: (602) 771-2744
More informationSecond Annual Florida 2008 Electronic Prescribing Report
Second Annual Florida 2008 Electronic Prescribing Report FLORIDA CENTER FOR HEALTH INFORMATION AND POLICY ANALYSIS AGENCY FOR HEALTH CARE ADMINISTRATION JANUARY 2009 Better Health Care for All Floridians
More informationEPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationPitfalls of Working in Family Medicine Presented by:
Pitfalls of Working in Family Medicine Presented by: www.thehealthlawfirm.com Main Office: 1101 Douglas Avenue Altamonte Springs, Florida 32714 Phone: (407) 331-6620 Fax: (407) 331-3030 Website: www.thehealthlawfirm.com
More informationPROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R047-15. September 15, 2015
PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY LCB File No. R047-15 September 15, 2015 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY:
More informationPMP AWAR X E. User Support Manual V 1.2
PMP AWAR X E User Support Manual V 1.2 04/09/2014 1 Contents 1 What Is a Requestor?... 3 2 Registration... 3 2.1 Registration Process... 3 2.2 Registering as a Delegate... 7 2.3 Email Verification... 11
More informationPrescription Monitoring Programs: Creating a National Network
Prescription Monitoring Programs: Creating a National Network Danna E. Droz, JD, RPH PMP Liaison ddroz@nabp.net 847/391-4508 United States Drug Enforcement Administration National Conference on Pharmaceutical
More informationColorado. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Colorado State Board of Pharmacy Pharmacy Board http://www.hidinc.com/copdmp pdmpinqr@state.co.us Rivera, Janina - PDMP Administrator
More informationIdaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Idaho Board of Pharmacy Pharmacy Board http://idaho.pmpaware.net pmp@bop.idaho.gov Anderson, Teresa - Program Information Coordinator
More informationHow To Write An Eprescription In Dubai
Page 1 of 6 patient medical records and eligibility available at the moment of prescribing and dispensing the medication. Serving the insured population in Dubai What is an e-prescription? It is the computer-based
More informationIllinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Berberet, Craig - PMP Manager 401 N Fourth St, Rm 126 Springfield IL 62702 Office: (217) 558-0943 Fax: (217) 557-7975 Email: PIL Department
More informationHOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 103 Medicinal Drug Prescriptions SPONSOR(S): Quinones TIED BILLS: IDEN./SIM. BILLS: SB 132 (i) REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care
More informationFREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationSubject: Health; prescription drugs; Vermont Prescription Monitoring 5 System
0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill
More informationPrescriptive Authority FAQ: Washington CRNAs
: Washington CRNAs This FAQ (Frequently Asked Questions) is maintained by. If you have comments or a question that is not answered here, please send it to wana1@comcast.net. DISCLAIMER: Please remember,
More informationARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:
ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:
More informationGuam. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Naval, Cynthia L. - Planner IV 123 Chalan Kareta Mangilao GU 96913-6304 Office: (671) 735-7204 Fax: (671) 734-5556 Email: GPDMP Guam
More informationNH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
More informationExceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015
Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the
More informationDIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292
DIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292 COMMUNITY PHARMACY PERMIT APPLICATION AND INFORMATION August 2012
More information(1) Program monitors multiple schedules of medications (at least Schedules II-IV) (see below Section 3: Purpose)
ESSENTIAL ELEMENTS OF AN ELECTRONIC PRESCRIPTION MONITORING PROGRAM There currently is a wide variety of factors that characterize state electronic Prescription Monitoring Programs (PMPs), which originated
More informationPrince Edward Island Drug Information System. Privacy and Security Awareness Training
Prince Edward Island Drug Information System Privacy and Security Awareness Training Purpose of the DIS The purpose of the PEI Drug Information System is established in section two (2) of the Pharmaceutical
More informationTechnical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity
Technical Assistance Guide PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity This project was supported by Grant No. 2011-PM-BX-K001 awarded by the Bureau of Justice Assistance.
More informationPrescription Drug Monitoring Programs
Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics
More informationBoard of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015
Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy Disclosure I have nothing to disclose and further, I was not paid an honorarium or travel reimbursement
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationState of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual
State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as
More informationManaged Care Program
Summit Workers Compensation Managed Care Program FLORIDA How to obtain medical care for a work-related injury or illness. Welcome The Summit workers compensation managed-care arrangement (Summit MCA)
More informationSession 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER
Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationTraining Guide for Data Requesters
Office of Substance Abuse and Mental Health Services Maine Department of Health and Human Services Prescription Monitoring Program October 2015 Contents Contents 1 System Overview... 1 About RxSentry and
More informationMichael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy
Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Legislative changes PDMP program changes 503B outsourcing facilities Rules changes Ph800 review Ph300 Ph400 Ph700 Current issues
More informationLEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322
LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - IN THE SENATE SENATE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 0 AN ACT RELATING TO EPINEPHRINE AUTO-INJECTORS; AMENDING
More informationDispenser s Implementation Guide Version 1.11
Dispenser s Implementation Guide Version 1.11 Florida Department of Health Prescription Drug Monitoring Program eptember 2012 This project was supported by Grant No. 2009-PM-BX-4004 awarded by the Bureau
More informationDEA REGISTRATION FEES FACT SHEET
DEA REGISTRATION FEES FACT SHEET Summary On April 16, 2012,the Drug Enforcement Administration (DEA) will implement an adjustment to the fees it charges to DEA registrants. For the vast majority of registrants
More informationCHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.
CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. Direct supervision means that a licensed pharmacist
More informationDrug Diversion. Controlled Substance Prescribing and Diversion
Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation
More informationIAC 12/12/12 Pharmacy[657] Ch 5, p.1 CHAPTER 5 PHARMACY SUPPORT PERSONS
IAC 12/12/12 Pharmacy[657] Ch 5, p.1 CHAPTER 5 PHARMACY SUPPORT PERSONS 657 5.1(155A) Definitions. For purposes of this chapter, the following definitions shall apply: Board means the Iowa board of pharmacy.
More informationCAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs
The Council of State governments CAPITOL research APRIL 00 Prescription Drug Monitoring Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State Governments Misuse of
More informationPrescription Drug Monitoring Program. A Powerful Tool
Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose
More informationCRS Report for Congress
Order Code RS22310 October 28, 2005 CRS Report for Congress Received through the CRS Web Hurricane Katrina: HIPAA Privacy and Electronic Health Records of Evacuees Summary Gina Marie Stevens Legislative
More informationRHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL
RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: October 13, 2014 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 Fax: 866-282-7076 RIRxReport@otech.com
More informationPRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA
PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationI-STOP: What You Need to Know. Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013
I-STOP: What You Need to Know Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013 What is I-STOP? Objectives Why is I-STOP necessary and how is it relevant
More information3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:
Commonwealth of Massachusetts Department of Public Health, Office of Prescription Monitoring and Drug Control 99 Chauncy Street, Boston, MA 02111 Tel: 617-753-7310 Email: mapmp.dph@state.ma.us MA ONLINE
More informationEMR Technology Checklist
Patient Accessibility/Scheduling/Account Maintenance: Able to interact with schedule through an online portal pre register VIP status to move patient to the front of the line Access and pre registration
More informationNOTICES OF PROPOSED RULEMAKING
NOTICES OF PROPOSED RULEMAKING Unless exempted by A.R.S. 41-1005, each agency shall begin the rulemaking process by first submitting to the Secretary of State s Office a Notice of Rulemaking Docket Opening
More informationPrescription Drug Monitoring Program Center of Excellence at Brandeis
Prescription Drug Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 4.1 Using PDMPs to Improve Medical Care: Washington State s Data Sharing Initiative with Medicaid and Workers
More informationLOUISIANA PRESCRIPTION MONITORING PROGRAM
LOUISIANA PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL - VERSION 1.0 Revision History Date Version Description Author 12/13/2013 1.0 Initial version Lena Roe (Otech) 1/28/2014 1.1 Updates Lena
More informationHOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR
HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 371 CS Cancer Drug Donation Program SPONSOR(S): Harrell TIED BILLS: IDEN./SIM. BILLS: SB 1310 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care General
More informationDivision II Medical/Pharmaceutical Services, Education and Oversight Sen. Carson (Thursday) 12/14/2015
Division II Medical/Pharmaceutical Services, Education and Oversight Carson (Thursday) 12/14/2015 Topic -Division II Expanding Board of Medicine; including practitioner of pain medicine or anesthesiology
More information